Skip to main content
PMC home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2000 Apr 5;6(1):23–29. [Article in French] doi: 10.1016/0924-4204(96)83603-1

Le virus respiratoire syncytial: importance en pathologie, méthodes diagnostiques, traitement et prévention

François Freymuth 1, Geneviève Eugène 1, Jacques Brouard 1, Astrid Vabret 1, Joëlle Petitjean 1, Françoise Bonnin 1
PMCID: PMC7146807  PMID: 32288233

The content is available as a PDF (1,020.3 KB).

RéfÉrences

  • 1.Agius G, Dindinaud G, Biggar EG. An epidemic of respiratory syncitial virus in elderly poeple: clinical and serological findings. J Med Virol. 1990;30:117–127. doi: 10.1002/jmv.1890300208. [DOI] [PubMed] [Google Scholar]
  • 2.Aherne W, Bird T, Court SDM. Pathological changes in virus infection of the lower respiratory tract in children. J Clin Pathol. 1970;23:7–18. doi: 10.1136/jcp.23.1.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Anderson LJ, Hierholzer JC, Tsou C, Hendry RM, Fernie BF, Stone Y, McIntosh K. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J Infect Dis. 1985;151:626–633. doi: 10.1093/infdis/151.4.626. [DOI] [PubMed] [Google Scholar]
  • 4.Aujard Y, Bedu A. Traitement des infections à virus respiratoire syncytial (VRS) de l'enfant. Med Mal Infect. 1992;22:88–92. [Google Scholar]
  • 5.Belshe RB, Van Voris LP, Mufson MA. Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial. J Infect Dis. 1982;4:311–319. doi: 10.1093/infdis/145.3.311. [DOI] [PubMed] [Google Scholar]
  • 6.Bourgeois C, Corvalsier C, Bour JB, Kohl E, Pothier P. Use of synthetic peptides to locate neutralising antigenic domains on the fusion protein of respiratory syncytial virus. J Gen Virol. 1991;72:1051–1058. doi: 10.1099/0022-1317-72-5-1051. [DOI] [PubMed] [Google Scholar]
  • 7.Brugère-Picoux J. Le virus respiratoire syncytial bovin. Bull Soc Vet Prat Fr. 1992;76:21–47. [Google Scholar]
  • 8.Chanock RM, Roitzam B, Myers R. Recovery of infants with respiratory illness of a virus related to chimpanzee coryza agant (CCA). Isolation properties and characterization. Am J Hyg. 1957;66:281–290. doi: 10.1093/oxfordjournals.aje.a119901. [DOI] [PubMed] [Google Scholar]
  • 9.Collins PL. The molecular biology of respiratory syncytial virus (RS) of the genus Pneumovirus. In: Kingsbury DW, editor. The Paramyxoviruses. Plenum Publishing Corporation; Boston: 1991. pp. 1103–1162. [Google Scholar]
  • 10.Cubie HE, Inglis JM, Leslie EE, Edmunds AT, Totapally B. Detection of respiratory syncytial virus in acute bronchiolitis in infants. J Med Virol. 1992;38:227–283. doi: 10.1002/jmv.1890380410. [DOI] [PubMed] [Google Scholar]
  • 11.Englund JA, Sullivan CJ, Jordon MC, Dehner MP, Vercellotti GM, Balfour HH. Respiratory syncytial virus infection in immunocompromised adults. Ann Intern Med. 1988;109:203–208. doi: 10.7326/0003-4819-109-3-203. [DOI] [PubMed] [Google Scholar]
  • 12.Everard ML, Milner AD. The respiratory syncytial virus and its role in acute bronchiolitis. Eur J Pediatr. 1992;151:638–651. doi: 10.1007/BF01957564. [DOI] [PubMed] [Google Scholar]
  • 13.Faden H, Kaul TN, Ogra PL. Activation of oxidative and arachidonic acid metabolism in neutrophils by respiratory syncytial virus antibody complexes: possible role in diseases. J Infect Dis. 1983;148:110–116. doi: 10.1093/infdis/148.1.110. [DOI] [PubMed] [Google Scholar]
  • 14.Floret D, Stamm D, Desplanques L, Devictor D. Les formes graves de bronchiolites. Med Mal Infect. 1993;23:839–843. [Google Scholar]
  • 15.Freymuth F. Rapid diagnosis of respiratory syncytial virus infections in children. Lancet. 1980;II:539–540. doi: 10.1016/s0140-6736(80)91866-8. [DOI] [PubMed] [Google Scholar]
  • 16.Freymuth F, Quibriac M, Petitjean J, Daon F, Amiel ML. Les virus responsables d'infections respiratoires en pédiatrie. Bilan de 3 480 aspirations nasales réalisées chez l'enfant en une période de six ans. Ann Pediatr (Paris) 1987;34:493–501. [PubMed] [Google Scholar]
  • 17.Freymuth F, Petitjean J, Pothier P, Brouard J, Norrby E. Prevalence of respiratory syncytial virus subgroups A and B in France from 1982 to 1990. J Clin Microbiol. 1991;29:653–655. doi: 10.1128/jcm.29.3.653-655.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Freymuth F, Petitjean J, Eugene-Ruellen G, Vabret A, Brouard J, Duhamel JF, Guillois B. Diagnostic des infections à virus respiratoire syncytial. Med mal Infect HS. 1993:824–829. [PubMed] [Google Scholar]
  • 19.Gouyon JB, Huet F, François C, Mabille JP. Infections à virus respiratoire syncytial du nouveau-né. Med Mal Infect. 1993;23:834–838. [Google Scholar]
  • 20.Grimprel E, François P, Olivier C. Epidemiologie clinique et virologique de la bronchiolite du nourrison. Enquête nationale multicentrique. Med Mal Infect. 1993;23:844–850. [Google Scholar]
  • 21.Groothuis GR, Woodin KA, Katz R, Robertson AD, McBride JT, Hall VB. Early ribavirin treatment of respiratory syncytial virus infection in high-risk children. J Pediatr. 1990;117:792–798. doi: 10.1016/s0022-3476(05)83347-5. [DOI] [PubMed] [Google Scholar]
  • 22.Groothuis JR, Simoes EA, Levin MJ. Prophylactic administration of respiratory syncytial virus immunoglobulin to high-risk infants and young children. N Engl J Med. 1993;329:1524–1530. doi: 10.1056/NEJM199311183292102. [DOI] [PubMed] [Google Scholar]
  • 23.Hall CB, Gelman JM, Biggar R, Kotor DI, Hogan PM, Douglas RG. Respiratory syncytial virus infection within families. N Engl J Med. 1976;294:414–419. doi: 10.1056/NEJM197602192940803. [DOI] [PubMed] [Google Scholar]
  • 24.Hall CB, McBride JT, Walsh EE. Aerosolized ribavirin treatment of infants with respiratory syncytial virus infection. A randomized double-blind study. N Engl J Med. 1983;308:1443–1447. doi: 10.1056/NEJM198306163082403. [DOI] [PubMed] [Google Scholar]
  • 25.Hall CB, Hall WJ, Gala CL, McGill FB, Leddy JP. Long-term prospective study in children after respiratory syncytial virus infection. J Pediatr. 1984;105:358–364. doi: 10.1016/s0022-3476(84)80005-0. [DOI] [PubMed] [Google Scholar]
  • 26.Hall CB, Powell KR, Schnabel KC, Gala CL, Pincus PH. Risk of secondary bacterial infection in infants hospitalized with respiratory syncytial virus infection. J Pediatr. 1988;113:266–271. [PubMed] [Google Scholar]
  • 27.Hall CB, Walsh EE, Schnabel KC, Long CE, McConnochie KM, Hildreth SW, Anderson LJ. Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemic and clinical characteristics in hospitalized and ambulatory children. J Infect Dis. 1990;162:1283–1290. doi: 10.1093/infdis/162.6.1283. [DOI] [PubMed] [Google Scholar]
  • 28.Hemming VG, Rodriguez W, Kim HW. Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children. Antimicrob Agents Chemother. 1987;32:1882–1886. doi: 10.1128/aac.31.12.1882. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Henderson FW, Collier AM, Clyde WA, Denny FW. Respiratory syncytial virus infections, reinfections and immunity: a prospective longitudinal study in young children. N Engl J Med. 1979;300:530–534. doi: 10.1056/NEJM197903083001004. [DOI] [PubMed] [Google Scholar]
  • 30.Higgins PG, Barrow GI, Tyrrell DA, Isaacs D, Gauci CL. The efficacity of intranasal Interferon alpha-2a in respiratory syncytial virus infection in volunteers. Antiviral Res. 1990;14:3–10. doi: 10.1016/0166-3542(90)90061-B. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Holberg CJ, Wright AL, Martinez FD, Ray CG, Taussig LM, Lebowitz MD. Risk factors for respiratory syncytial virus-associated lower respiratory illness in the first year of life. Am J Epidemiol. 1991;133:1135–1151. doi: 10.1093/oxfordjournals.aje.a115826. [DOI] [PubMed] [Google Scholar]
  • 32.Hong Dang Bui R, Molinaro GA, Kettering JD, Heiner DG, Imagawa DT, StGeme JW. Virus specific IgE and IgG4 in serum of infants infected with respiratory syncytial virus. J Pediatr. 1987;110:87–90. doi: 10.1016/s0022-3476(87)80295-0. [DOI] [PubMed] [Google Scholar]
  • 33.Isaacs D. Production of interferon in respiratory syncytial virus bronchiolitis. Arch Dis Child. 1986;64:92–95. doi: 10.1136/adc.64.1.92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Isaacs D. Production of interferon in respiratory syncytial virus bronchiolitis. Arch Dis Child. 1986;64:92–95. doi: 10.1136/adc.64.1.92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Kim HW, Canchola GJ, Brandt CD. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol. 1969;89:422–434. doi: 10.1093/oxfordjournals.aje.a120955. [DOI] [PubMed] [Google Scholar]
  • 35.Krasinski K. Severe respiratory syncytial virus infection: clinical features, nosocomial acquisition and outcompe. Pediatr Infect Dis. 1985;4:250–257. doi: 10.1097/00006454-198505000-00009. [DOI] [PubMed] [Google Scholar]
  • 36.McConnochie KM, Hall CB, Walsh EE, Roghmann KJ. Variation in severity of respiratory syncytial virus infections with subtype. J Pediatr. 1990;117:52–62. doi: 10.1016/s0022-3476(05)82443-6. [DOI] [PubMed] [Google Scholar]
  • 37.Midulla F, Villani A, Panuska JR, Dab I, Kolls JK, Merolla R, Ronchetti R. Respiratory syncytial virus lung infection in infants: immunoregulatory role of infected alveolar macrophages. J Infect Dis. 1993;168:1515–1519. doi: 10.1093/infdis/168.6.1515. [DOI] [PubMed] [Google Scholar]
  • 38.Mufson MA, Orvell C, Rafnar B, Norrby E. Two distinct subtypes of respiratory syncytial virus. J Gen Virol. 1985;66:2111–2124. doi: 10.1099/0022-1317-66-10-2111. [DOI] [PubMed] [Google Scholar]
  • 39.Mufson MA, Akerlind-Stopner B, Belshe B, Norrby E. A single season epidemic with respiratory syncytial subgroup B2 during 10 epidemic years, 1978 to 1988. J Clin Microbiol. 1991;29:162–165. doi: 10.1128/jcm.29.1.162-165.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Paton AW, Paton JC, Lawrence AJ, Goldwater PN, Harris RJ. Rapid detection of respiratory syncytial virus in nasopharyngeal aspirates by reverse transcription and polymerase chain reaction amplification. J Clin Microbiol. 1992;30:901–904. doi: 10.1128/jcm.30.4.901-904.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Peigue-Lafeuille H, Gazuy N, Mignot P, Deteix P, Beytout D, Baguet JC. Severe respiratory syncytial viral pneumonia in an adult renal transplant patient: successful treatment with ribavirin. Scand J Infect Dis. 1990;22:87–89. doi: 10.3109/00365549009023124. [DOI] [PubMed] [Google Scholar]
  • 42.Piazza FM, Johnson SA, Ottolini MG. Immunotherapy of respiratory syncytial virus infection in cotton rats (Sigmodon fulviventer) using IgG in a small-particle aerosol. J Infect Dis. 1992;166:1422–1424. doi: 10.1093/infdis/166.6.1422. [DOI] [PubMed] [Google Scholar]
  • 43.Portnoy J, Hicks R, Pachoce F, Olson L. Pilot study of recombinant interferon Alpha-2 for treatment of infants with bronchiolitis induced by respiratory syncytial virus. Antimicrob Agent Chemother. 1988;32:589–591. doi: 10.1128/aac.32.4.589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Pothier P. Virus respiratoire syncytial et réponse immunitaire: du diagnostic de l'infection aux perspectives de vaccination. Pediatr. 1991;46:1–4. (suppl) [PubMed] [Google Scholar]
  • 45.Price JF. Acute and long term effects of viral bronchiolitis in infancy. Lung. 1990;168:414–421. doi: 10.1007/BF02718159. [DOI] [PubMed] [Google Scholar]
  • 46.Prince GA, Hemming VG, Horswood RL, Chanock RM. Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat. Virus Res. 1985;3:193–206. doi: 10.1016/0168-1702(85)90045-0. [DOI] [PubMed] [Google Scholar]
  • 47.Reinert P. De la prévention au traitement des infections à virus respiratoire syncytial. Pédiatrie. 1991;46:10–13. [PubMed] [Google Scholar]
  • 48.Salkind AR, McCarthy DO, Nichols JE, Domurat FM, Walsh EE, Roberts NJ. Interleukine-1 inhibitor activity induced by respiratory syncytial virus: abrogation of virus specific and alternate human lymphocyte proliferation responses. J Infect Dis. 1991;163:71–77. doi: 10.1093/infdis/163.1.71. [DOI] [PubMed] [Google Scholar]
  • 49.Smith DW, Frankel RL, Mathers LH, Tang ATS, Ariagno RL, Prober CG. A controled trial of aeorolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection. N Engl J Med. 1991;325:24–29. doi: 10.1056/NEJM199107043250105. [DOI] [PubMed] [Google Scholar]
  • 50.Storch GA, Anderson LA, Park CS, Tsou C, Dohner DE. Antigenic and genomic diversity within group A respiratory syncytial virus. J Infect Dis. 1991;163:811–858. doi: 10.1093/infdis/163.4.858. [DOI] [PubMed] [Google Scholar]
  • 51.Sullender WM, Sun L, Anderson LJ. Analysis of respiratory syncytial virus genetic variability with amplified cDNAs. J Clin Micnbiol. 1993;31:1224–1231. doi: 10.1128/jcm.31.5.1224-1231.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Taber LH, Knight V, Gilbert VE. Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants. Pediatr. 1983;72:613–618. [PubMed] [Google Scholar]
  • 53.Taylor CE, Morrow S, Scott M, Young B, Toms GL. Comparative virulence of respiratory syncytial virus subgroups A and B. Lancet. 1989;I:777–778. doi: 10.1016/s0140-6736(89)92592-0. [DOI] [PubMed] [Google Scholar]
  • 54.Ward KA, Lambden PR, Ogilvie MM, Watt PJ. Antibodies to respiratory syncytial virus polypeptides and their significance in human infection. J Gen Virol. 1983;64:1867–1876. doi: 10.1099/0022-1317-64-9-1867. [DOI] [PubMed] [Google Scholar]
  • 55.Welliver RC, Kaul TN, Ogra PL. Cell mediated immune response to respiratory syncytial virus infection: relationship to the development of reactive airway disease. J Pediatr. 1979;94:370–375. doi: 10.1016/s0022-3476(79)80573-9. [DOI] [PubMed] [Google Scholar]
  • 56.Welliver RC, Kaul TN, Putnam TI, Sun M, Riddleberger K, Ogra PL. The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses. J Pediatr. 1980;96:808–813. doi: 10.1016/s0022-3476(80)80547-6. [DOI] [PubMed] [Google Scholar]
  • 57.Welliver RC, Wong DT, Sun M, Middleton E, Vaughan RS, Ogra PL. The development of respiratory syncytial virus specific IgE and the release of histamine in nasopharyngeal secretions after infections. N Engl J Med. 1981;305:841–846. doi: 10.1056/NEJM198110083051501. [DOI] [PubMed] [Google Scholar]
  • 58.Welliver RC. Detection, pathogenesis and therapy of respiratory syncytial virus infections. Clin Microbiol Rev. 1988;1:27–39. doi: 10.1128/cmr.1.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Wright PF, Belshe RB, Kim HW, Van Voris LP, Chanock RM. Administration of a highly attenuated, live respiratory syncytial virus vaccine in adults and children. Infect Immun. 1982;37:397–400. doi: 10.1128/iai.37.1.397-400.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annales De L'Institut Pasteur. Actualites are provided here courtesy of Elsevier

RESOURCES